[1] | Narayanaswami P, Weiss M, Selcen D, et al. Evidence-based guideline summary: diagnosis and treatment of limb-girdle and distal dystrophies: report of the guideline development subcommittee of the American Academy of Neurology and the practice issues review panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Neurology 2014; 83(16):1453. |
|
[2] | Wicklund MP, Kissel JT. The limb-girdle muscular dystrophies. Neurol Clin 2014; 32:729. |
|
[3] | Bushby KM. Limb-Girdle Muscular Dystrophies. National Organization of Rare Disorders. http://rarediseases.org/rare-diseases/limb-girdle-muscular-dystrophies/. Accessed March 8, 2016. |
|
[4] | Norwood FL, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain 2009;132: 3175-3186. |
|
[5] | Darras BT. Limb-girdle muscular dystrophy. UpToDate, Waltham, MA. (Accessed on March 10, 2016.). |
|
[6] | Okere A, Reddy S, Gupta S, et al. A Cardiomyopathy in a Patient With Limb Girdle Muscular Dystrophy Type 2A. Circulation: Heart Failure. 2013; 6: e12-e13. |
|
[7] | Norwood F, de Visser M, Eymard B, Lochmϋller H, Bushby K. EFNS guideline on diagnosis and management of limb girdle muscular dystrophies. Eur J Neurol. 2007; 14:1305-1312. |
|
[8] | Hong JS, Ki CS, Kim JW, et al. Cardiac Dysrhythmias, Cardiomyopathy and Muscular Dystrophy in Patients with Emery-Dreifuss Muscular Dystrophy and Limb-Girdle Muscular Dystrophy Type 1B. J Korean Med Sci. 2005 Apr;20(2):283-290. |
|
[9] | van der Kooi A, de Voogt W, Barth P, et al. The heart in limb girdle muscular dystrophy. Heart 1998;79:73-77. |
|
[10] | Verhaert D, Richards K, Rafael-Fortney JA, Raman SV. Cardiac Involvement in Patients With Muscular Dystrophies: Magnetic Resonance Imaging Phenotype and Genotypic Considerations. Circ Cardiovasc Imaging. 2011;4:1 67-76. |
|
[11] | Kalaria VG, Passannante MR, Shah T, et al. Effect of mitral regurgitation on left ventricular thrombus formation in dilated cardiomyopathy. Am Heart J. 1998;135 2 pt 1:215-220. |
|
[12] | Falk RH, Foster E, Coats MH et al. Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective follow-up study. Am Heart J. 1992;123:136-142. |
|
[13] | Stratton JR, Resnick AD. Increased embolic risk in patients with left ventricular thrombi. Circulation. 1987;75:1004-1011. |
|
[14] | Lip GY, Manning WJ, Weissman NJ. Left ventricular thrombus after acute myocardial infarction. UpToDate, Waltham, MA. (Accessed on March 10, 2016.). |
|
[15] | Vaitkus PT, Barnathan ES. Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis. J Am Coll Cardiol. 1993;22(4):1004. |
|
[16] | Finsterer J, Stöllberger C: Atrial fibrillation/flutter in myopathies. Int J Cardiol 2008, 128:304-310. |
|
[17] | Chen C-H, Tang S-C, Su Y-N, Yang C-C, Jeng J-S. Cardioembolic stroke related to limb-girdle muscular dystrophy 1B. BMC Research Notes. 2013;6:32. |
|
[18] | Ambrosi P, Mouly-Bandini A, Attarian S, et al. Heart transplantation in 7 patients from a single family with limb-girdle muscular dystrophy caused by lamin A/C mutation. Int J Cardiol. 2009;137(3):e75. |
|
[19] | Margeta M, Connolly AM, Winder TL, et al. Cardiac pathology exceeds skeletal muscle pathology in two cases of limb-girdle muscular dystrophy type 2I. Muscle Nerve. 2009;40(5):883. |
|
[20] | Meune C, Van Berlo JH, Anselme F, Bonne G, Pinto YM, Duboc D: Primary prevention of sudden death in patients with lamin A/C gene mutations.N Engl J Med 2006, 354:209-210. |
|